FIECON is supporting a breakthrough therapy in the accelerated approval regulatory process by assembling a global evidence package to expedite EMA submission and approval alongside the FDA.
We are technically astute, with experts who bring deep healthcare strategy and clinical knowledge to every project.
AI-assisted SLR
We conduct SLRs to HTA using AI technology, addressing:
Adherence to HTA by completing all systematic review steps to meet evidentiary requirements.
A unified SLR protocol, incorporating multi-database searches, quality-controlled screening, and meta-analyses of RCTs.
Standardized, replicable templates leveraging dynamic HTA formats and workflows to satisfy HTA needs.
Harmonized HTA, aligning with JCA requirements for 2025.
Infrastructure for replicable SLRs for HTA and PICOs
We define clinical lexicons and ontologies by disease state.
We create templates for HTA archetypes and scientific platforms, and adapt past projects for regulatory use.
We execute AI-assisted SLRs in real time, satisfying 10+ PICOs across multiple markets.
Practical Agility
Accelerating business objectives in tight timelines:
We shorten timelines by eliminating duplicative efforts across departments and embedding scientific best practices.
We leverage the newest AI technology to meet key business goals efficiently.
FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”
Senior Market Access Manager, Mid-sized Pharma
It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”
Associate Director, Mid-sized Pharma
FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”
Market Access Director, Small Biotech
FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”
Disease Area Director, Big Pharma
The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”
Executive Director, Biotech
FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”
Value Demonstration & Access Lead, Big Pharma
It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”
Senior Vice President, Small Biotech
FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts.
